Thermo Fisher Scientific Restricted Cash decreased by 20.0% to $4.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 75.0%, from $16.00M to $4.00M. Over 5 years (FY 2020 to FY 2025), Restricted Cash shows a downward trend with a -12.9% CAGR.
An increase may signal higher debt service requirements or increased collateral obligations, while a decrease may indicate the release of restricted funds.
Cash balances that are legally or contractually set aside for specific purposes, such as debt service reserves, collater...
Common in capital-intensive industries like energy where project financing requires specific reserve accounts.
restricted_cash| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.00M | $20.00M | $13.00M | $26.00M | $16.00M | $14.00M | $12.00M | $11.00M | $13.00M | $10.00M | $6.00M | $7.00M | $11.00M | $11.00M | $10.00M | $16.00M | $3.00M | $7.00M | $5.00M | $4.00M |
| QoQ Change | — | +81.8% | -35.0% | +100.0% | -38.5% | -12.5% | -14.3% | -8.3% | +18.2% | -23.1% | -40.0% | +16.7% | +57.1% | +0.0% | -9.1% | +60.0% | -81.3% | +133.3% | -28.6% | -20.0% |
| YoY Change | — | — | — | — | +45.5% | -30.0% | -7.7% | -57.7% | -18.8% | -28.6% | -50.0% | -36.4% | -15.4% | +10.0% | +66.7% | +128.6% | -72.7% | -36.4% | -50.0% | -75.0% |